Out and about in 2018

Members of the Evidence department attend a number of events throughout the year to talk, present or share insights. Below are further details of the events we have coming up in 2018.

NCRI Cancer Conference, 4-6 November 2018, Glasgow

The National Cancer Research Institute (NCRI) Conference takes place at the Scottish Event Campus in Glasgow on 4-6 November 2018.

It's the UK’s largest conference to showcase advances in cancer research – providing a platform for researchers, clinicians and industry representatives to discuss and present their latest findings.

As one of 19 partner organisations, Macmillan is delighted to attend the conference to promote how we prioritise, conduct and share our research – which delivers real impact for people living with cancer.


2018 Conference programme

This year, the NCRI has created an interdisciplinary programme in five streams:

  • Cancer discovery and underpinning research
  • Prevention
  • Early detection
  • Diagnosis and prognosis
  • Treatment and cancer control: living with and beyond cancer outcomes.

How is Macmillan taking part?

Macmillan will showcase research throughout the conference, including:

  • Sponsoring a session on 'The reality of cancer treatment consequences', co-chaired by Diana Greenfield – a Macmillan Consultant Nurse in Late Effects, who also sits on the Macmillan Research Advisory Panel.
  • Presenting our approach to system-wide change in health services, with findings from Improving the Cancer Journey (ICJ), including how artificial intelligence and interactive visualisation technology can improve service provision with data analysis.
  • An Igloo Session to outline how and why our support model works, and the impact it has for people living with cancer in Glasgow. A person living with cancer, who has used the service, will also share their experiences.

Macmillan-led and funded research

We will share research led by Macmillan and research funded by the Macmillan Research Grants Scheme. This includes e-posters, physical posters and presentations, with:

  • Analysis of the Cancer Workforce Census, which collected data on the size, distribution and support needs of the cancer workforce in England.
  • Joint analysis with NCRAS on the number of people living with treatable but not curable cancer.
  • Joint research with Public Health Wales into the prevalence and outcomes for people with cancer and other health conditions.
  • Making the case for prehabilitation in cancer care.
  • Three pieces of research from the Scottish Routes from Diagnosis framework, investigating:
    • Palliative opioid prescribing using patient-level community prescribing data
    • Common comorbidities in patients diagnosed with cancer
    • Survival differences in patients with multiple cancer diagnoses.
  • The outcomes of completing the Macmillan Quality Toolkit in Scottish GP practices.
  • Macmillan-funded research with the University of Southampton, including the latest findings from the ColoREctal Well-being (CREW) and HORIZONS studies.

Further information about our charity's research and funding partnerships, including our latest research publications, can be found on our website.

If you have any questions, please contact Evidence Engagement Officer Becky Gorringe, or Research Grants Officer Rhona Auckland.


Public Health England’s National Cancer Registration and Analysis Service, 20-21 June 2018, Manchester

In June, members of the Evidence department represented Macmillan at Public Health England’s Cancer Services, Data and Outcomes Conference in Manchester. This annual two-day event allows us to promote how Macmillan is using data, research and evaluations to make an impact and drive improvements in cancer care and support.

The conference attracts prominent members of the cancer data community, researchers, policy makers and clinicians. It provides an important platform to raise Macmillan’s profile as an expert on the 2.5 million people living with cancer in the UK, and the data partnerships we maintain across the UK.

The conference explored how data is being used to prevent, diagnose and help treat people with cancer using research from leading experts, as well as how novel data sets, sources and innovations in the use of cancer data can help make changes to service delivery and quality of patient care.

Macmillan was heavily involved in delivering sessions during the conference, we:

  • Sponsored a Q&A workshop on data access in the age of GDPR, opt-out and informed choice.
  • Presented posters on the latest Macmillan-led, Macmillan-funded and joint research with national cancer registries. Colm Burns (Evidence Officer, Northern Ireland) received the Runner Up Prize for Best Scientific Poster for his work on ‘Exploring the caseload, activities and outcomes of a regional acute oncology service’ [PDF].
  • Chaired parallel sessions on using data across the pathway, patient experience and outcomes, quality of life and living with and beyond cancer.

Macmillan-funded researchers also delivered the following programmed sessions:

  • Reviewing quality of life following colorectal cancer surgery.
  • Impact of prior health on predicted survival of melanoma.
  • Aspects of patient experience that predict satisfaction with care (speed presentation). Read the news coverage on the Medical Xpress website

As always, the event was well attended by members of the cancer data and research community and cancer patients and representatives. For more information on the conference and any downloadable slides, please visit the Public Health England website.

Macmillan evidence staff stand behind a Macmillan-branded stall with leaflets and speak to conference attendees.